Last reviewed · How we verify
NCT06596980: POPPINS-CE
Examining the Effect of a Digital Medical Device for Cognitive and Musical Training in Children With Reading Disabilities
NA trial testing Poppins Clinical in Learning Disorders, Specific in 38 participants. Completed in 11 February 2025.
11 February 2025
Quick facts
| Lead sponsor | Poppins |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 28 June 2024 |
| Primary completion | 11 February 2025 |
| Estimated completion | 11 February 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Poppins Clinical
Conditions studied
- Learning Disorders, Specific — all drugs for Learning Disorders, Specific →
- Learning Disabilities — all drugs for Learning Disabilities →
- Specific Learning Disorder, With Impairment in Reading — all drugs for Specific Learning Disorder, With Impairment in Reading →
- Dyslexia — all drugs for Dyslexia →
Sponsor
Poppins
Who can join
Adults 7 to 11, any sex, with Learning Disorders, Specific or Learning Disabilities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the effect on reading skills of the digital medical device Poppins Clinical for cognitive and musical training in pediatric participants (ages 7-11) with a specific learning disability with reading deficit. The main objective of the study is to assess the evolution in reading skills through a word reading task before and after the intervention. Participants will be asked to train with the digital medical device Poppins Clinical 5 times per week for 8 weeks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Children's Improvement After Language and Rhythm Training With the Digital Medical Device Poppins for Dyslexia: Single-Arm Intervention Study.
Grossard C, Descamps M, Pellerin H, Vonthron F, et al · · 2025 · PMID 40750096 · DOI 10.2196/76435
Verify or expand the search:
- PubMed search for NCT06596980
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Poppins Clinical
Trials testing the same drug.
- NCT06902610 — Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive · recruiting
- NCT06592911 — Examining the Effect of a Digital MD for Cognitive and Musical Training + Reduced Conventional SOC on the Reading and Wr · NA · completed
Other Poppins trials
Trials by the same sponsor.
- NCT06902610 — Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive · recruiting
- NCT06592911 — Examining the Effect of a Digital MD for Cognitive and Musical Training + Reduced Conventional SOC on the Reading and Wr · NA · completed
- NCT05154721 — Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06596980 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poppins
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596980.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing